Amylyx Pharmaceuticals, Inc. Gains 63.84%
Tue, Aug 18, 2026 at 07:33 PM
Amylyx Pharmaceuticals, Inc. (AMLX:NASDAQ) soared at $35.11, a gain of 63.8%. On Tue, Aug 18, 2026, AMLX:NASDAQ hit a New 2-Week High of $35.11. The stock appeared on our News Catalysts scanner on Tue, Aug 18, 2026 at 05:37 PM in the 'PUBLIC OFFERING' category. From Tue, Aug 04, 2026, the stock recorded 30.00% Up Days and 36.36% Green Days
About Amylyx Pharmaceuticals, Inc. (AMLX:NASDAQ)
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Top 10 Gainers:
- Profusa Inc. (PFSA:NASDAQ), 506.62%
- FreeCast Inc. (CAST:NASDAQ), 144.24%
- Heritage Distilling Holding Co. Inc. (IPST:NASDAQ), 113.26%
- Xos, Inc. (XOS:NASDAQ), 112.44%
- AIxCrypto Holdings Inc Com Par $0.001 (AIXC:NASDAQ), 85.86%
- Super League Enterprise, Inc. (SLE:NASDAQ), 82.12%
- Amylyx Pharmaceuticals, Inc. (AMLX:NASDAQ), 63.84%
- Greenlane Holdings, Inc. (GNLN:NASDAQ), 51.74%
- PS International Group Ltd. (PSIG:NASDAQ), 47.22%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 42.07%